Literature DB >> 18400844

The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus.

Zhengbin Zhang1, Dylan Harris, Virendra N Pandey.   

Abstract

Hepatitis C virus (HCV) infection is the leading cause of liver cirrhosis and hepatocellular carcinoma and one of the primary indications for liver transplantation. The molecular mechanisms underlying the actions of host factors in HCV replication remain poorly defined. FUSE (far upstream element of the c-myc proto-oncogene) binding protein (FBP) is a cellular factor that we have identified as a binder of HCV 3' nontranslated region (3'NTR). Mapping of the binding site showed that FBP specifically interacts with the poly(U) tract within the poly(U/UC) region of the 3'NTR. Silencing of FBP expression by small interfering RNA in cells carrying HCV subgenomic replicons severely reduced viral replication, while overexpression of FBP significantly enhanced viral replication. We confirmed these observations by an in vitro HCV replication assay in the cell-free replicative lysate, which suggested that there is a direct correlation between the cellular FBP level and HCV replication. FBP immunoprecipitation coprecipitated HCV nonstructural protein 5A (NS5A), indicating that FBP interacts with HCV NS5A, which is known to function as a link between HCV translation and replication. Although FBP is mainly localized in the nucleus, we found that in MH14 cells a significant level of this protein is colocalized with NS5A in the cytosol, a site of HCV replication. While the mechanism of FBP involvement in HCV replication is yet to be delineated, our findings suggest that it may be an important regulatory component that is essential for efficient replication of HCV.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400844      PMCID: PMC2395142          DOI: 10.1128/JVI.00064-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome.

Authors:  T Ito; M M Lai
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs.

Authors:  X C Fan; J A Steitz
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

3.  RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein.

Authors:  S S Peng; C Y Chen; N Xu; A B Shyu
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

Review 4.  Molecular virology of hepatitis C virus.

Authors:  B Clarke
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

Review 5.  Hepatitis C and hepatocellular carcinoma.

Authors:  A M Di Bisceglie
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication.

Authors:  Peter Friebe; Ralf Bartenschlager
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

7.  Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X.

Authors:  K Tsuchihara; T Tanaka; M Hijikata; S Kuge; H Toyoda; A Nomoto; N Yamamoto; K Shimotohno
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.

Authors:  S Das; M Ott; A Yamane; W Tsai; M Gromeier; F Lahser; S Gupta; A Dasgupta
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  hnRNP C increases amyloid precursor protein (APP) production by stabilizing APP mRNA.

Authors:  L E Rajagopalan; C J Westmark; J A Jarzembowski; J S Malter
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

10.  A link between translation of the hepatitis C virus polyprotein and polymerase function; possible consequences for hyperphosphorylation of NS5A.

Authors:  Christopher J McCormick; David Brown; Stephen Griffin; Lisa Challinor; David J Rowlands; Mark Harris
Journal:  J Gen Virol       Date:  2006-01       Impact factor: 3.891

View more
  27 in total

1.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

2.  Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.

Authors:  Hyojeung Kang; Paul M Lieberman
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.

Authors:  Updesh Dixit; Ashutosh K Pandey; Zhihe Liu; Sushil Kumar; Matthew B Neiditch; Kenneth M Klein; Virendra N Pandey
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba.

Authors:  Dinesh Manvar; Mahesh Mishra; Suriender Kumar; Virendra N Pandey
Journal:  J Ethnopharmacol       Date:  2012-09-28       Impact factor: 4.360

5.  FUSE binding protein 1 interacts with untranslated regions of Japanese encephalitis virus RNA and negatively regulates viral replication.

Authors:  Hsu-Ling Chien; Ching-Len Liao; Yi-Ling Lin
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

Review 6.  Host factors in enterovirus 71 replication.

Authors:  Shin-Ru Shih; Victor Stollar; Mei-Ling Li
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

7.  Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.

Authors:  Priya Mishra; Updesh Dixit; Ashutosh K Pandey; Alok Upadhyay; Virendra N Pandey
Journal:  Virology       Date:  2016-10-19       Impact factor: 3.616

8.  Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.

Authors:  Uta Rabenhorst; Rasa Beinoraviciute-Kellner; Marie-Luise Brezniceanu; Stefan Joos; Frauke Devens; Peter Lichter; Ralf J Rieker; Jörg Trojan; Hye-Jung Chung; David L Levens; Martin Zörnig
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

Review 9.  Far upstream element binding protein 1: a commander of transcription, translation and beyond.

Authors:  J Zhang; Q M Chen
Journal:  Oncogene       Date:  2012-08-27       Impact factor: 9.867

10.  Far upstream element-binding protein 1 and RNA secondary structure both mediate second-step splicing repression.

Authors:  Huang Li; Zhijia Wang; Xuexia Zhou; Yuanming Cheng; Zhiqin Xie; James L Manley; Ying Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.